Discovery and optimization of novel 3-piperazinylcoumarin antagonist of chemokine-like factor 1 with oral antiasthma activity in mice.
about
IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.Chemokine-Like Factor 1 (CKLF-1) is Overexpressed in Keloid Patients: A Potential Indicating Factor for Keloid-Predisposed Individuals.Asthma research in China: a five-year review.Coumarin derivatives: an updated patent review (2012-2014).Design and synthesis of a series of pyrido[2,3-d]pyrimidine derivatives as CCR4 antagonists.A new antagonist for CCR4 attenuates allergic lung inflammation in a mouse model of asthma.
P2860
Discovery and optimization of novel 3-piperazinylcoumarin antagonist of chemokine-like factor 1 with oral antiasthma activity in mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Discovery and optimization of ...... l antiasthma activity in mice.
@ast
Discovery and optimization of ...... l antiasthma activity in mice.
@en
type
label
Discovery and optimization of ...... l antiasthma activity in mice.
@ast
Discovery and optimization of ...... l antiasthma activity in mice.
@en
prefLabel
Discovery and optimization of ...... l antiasthma activity in mice.
@ast
Discovery and optimization of ...... l antiasthma activity in mice.
@en
P2093
P356
P1476
Discovery and optimization of ...... l antiasthma activity in mice.
@en
P2093
Dongmei Wang
Guangyan Li
Jinfeng Hu
Mingna Sun
Naihong Chen
P304
P356
10.1021/JM901652P
P407
P577
2010-02-01T00:00:00Z